Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
Tatiana Cobo-IbañezAna Urruticoechea-AranaIñigo Rúa-FigueroaMaría A Martín-MartínezJuan Gabriel Ovalles-BonillaMaría GalindoJaime Calvo-AlénAlejandro OlivéAntonio Fernandez-NebroRaúl Menor-AlmagroEva TomeroLoreto HorcadaEsther Uriarte-ItzazelaiaVíctor M Martínez-TaboadaJosé Luis AndreuAlina BoteanuFrancisco Javier NarváezCristina BohorquezCarlos A Montilla-MoralesGregorio SantosBlanca Hernández-CruzPaloma VelaEva SalgadoMercedes FreireJosé Ángel Hernández-BeriainElvira Díez-ÁlvarezLorena ExpósitoOlaia Fernández-BerrizbeitiaMaría Luisa Velloso-FeijooMónica Ibáñez-BarcelóNuria Lozano-RivasGema BonillaMireia MorenoEnrique RayaVíctor Eliseo Quevedo-VilaTomas Ramón Vázquez-RodríguezJesús Ibáñez-RuanSantiago Muñoz-FernándezFernando Sánchez-AlonsoJosé María Pego-ReigosaPublished in: Arthritis care & research (2020)
Cancer incidence in patients with SLE was higher than in the Spanish population, particularly among young women. This increase might be due to non-HS cancers, which would be associated with SLE involving greater cumulative damage where more ACE inhibitors are prescribed.